THC Farmaceuticals, Inc. (CBDG) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

THC Farmaceuticals, Inc. (CBDG) Healthcare & Pipeline Overview

THC Farmaceuticals, Inc. specializes in owning and operating independent ATMs within third-party retail and commercial establishments, focusing on high-footfall areas in Utah's Wasatch Front region. As a subsidiary of Weed Growth Fund, Inc., the company facilitates cash access for small and medium-sized enterprises.

What Is the Investment Thesis for CBDG?

THC Farmaceuticals, Inc.'s investment profile is characterized by its niche operation in the independent ATM sector, with a reported network of eight machines as of mid-2015, concentrated in Utah's Wasatch Front. The company's value drivers stem from transaction fees generated by ATM usage in high-footfall commercial locations. Potential growth catalysts could include expanding its ATM network, diversifying into new geographic markets, or introducing additional services beyond basic cash dispensing. However, significant risks are present, including its extremely small operational scale with only two employees, a $0.00B market capitalization, and a negative Beta of -9.51, suggesting unusual market behavior. The company's OTC Other listing and 'Unknown' disclosure status also present substantial transparency and liquidity challenges for investors, further complicated by its misleading name given its actual ATM business.

Based on FMP financials and quantitative analysis

CBDG Key Highlights

Market Capitalization: $0.00B, indicating a micro-cap or non-operational status as of 2026-06-14.

• Employee Count: 2 employees, suggesting a very lean operational structure.
• ATM Network Size: 8 public-access ATMs reported as of June 30, 2015, concentrated in a single region.
• Geographic Concentration: Operations focused exclusively on Utah's Wasatch Front region.
• Beta: -9.51, indicating extreme inverse volatility relative to the broader market.

Who Are CBDG's Competitors?

CBDG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CBDG's Key Strengths?

Established network of 8 public-access ATMs as of mid-2015.

• Strategic placement in high-footfall retail and commercial establishments.
• Operational experience in the independent ATM sector since 2008.
• Subsidiary status under Weed Growth Fund, Inc.

What Are CBDG's Weaknesses?

Extremely small operational scale with only 2 employees and 8 ATMs (as of 2015).

• Limited geographic concentration to Utah's Wasatch Front region.
• Market capitalization of $0.00B, indicating minimal or no market value.
• Negative Beta of -9.51, suggesting extreme and unusual market behavior.

What Could Drive CBDG Stock Higher?

Unknown specific operational updates or expansion plans beyond the 2015 reported data.

• Any potential announcement regarding an increase in the ATM network size beyond the eight units reported in 2015.
• Disclosure of current financial results or operational performance metrics, which are presently unknown due to the company's 'Unknown' disclosure status.
• The continued operation of its existing network of independent ATMs, which serves as the primary source of transaction fee revenue for the company.

What Are the Key Risks for CBDG?

Financial-distress signal — its Altman Z-Score of -0.28 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-0.3%) — the business is not currently generating profit on shareholder capital.
• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Limited operational scale with only 2 employees and 8 ATMs reported as of mid-2015, posing significant challenges for substantial growth or market impact.
• The company's $0.00B market capitalization and OTC Other listing indicate extreme financial distress, minimal market value, or potentially non-operational status.
• Declining demand for cash transactions due to the widespread adoption of digital payment methods, which could severely impact ATM usage and revenue generation.
• High regulatory and disclosure uncertainty associated with its 'Unknown' disclosure status on the OTC Other tier, limiting investor access to critical information.
• Misleading company name ('THC Farmaceuticals, Inc.') which could lead to significant investor confusion regarding its actual business of ATM operations, rather than cannabis-related activities.

What Are the Growth Opportunities for CBDG?

• Expansion of ATM Network: The company could pursue strategic expansion beyond its current eight ATMs in Utah. Identifying new high-footfall retail and commercial establishments, such as additional hotels, convenience stores, or entertainment venues in other regions, presents a clear growth path. This would involve capital investment for new machine acquisition and deployment, alongside securing new placement agreements. The market for independent ATMs, while facing digital payment trends, still serves a vital role in cash access for consumers and small businesses, particularly in areas where traditional bank branches are scarce.
• Geographic Diversification: Currently concentrated in Utah's Wasatch Front region, THC Farmaceuticals, Inc. could explore opportunities in adjacent states or other underserved urban/suburban markets. This would mitigate regional economic risks and potentially tap into new customer bases. A phased approach, starting with neighboring states that exhibit similar demographic and commercial characteristics, could allow for controlled expansion while leveraging existing operational expertise. This strategy would broaden the company's footprint and enhance its revenue potential beyond its current limited scope.
• Enhanced Service Offerings: Beyond basic cash dispensing, the company could explore adding value-added services to its ATMs. This might include bill payment options, prepaid card top-ups, or even cryptocurrency purchasing capabilities, depending on regulatory frameworks. Such enhancements could attract a wider user base and generate additional transaction fees, diversifying revenue streams. Implementing these features would require technology upgrades and potential partnerships with service providers, but could significantly increase the utility and profitability of each ATM unit.
• Strategic Partnerships with Retailers: Forming deeper, more integrated partnerships with larger retail chains or hospitality groups could facilitate rapid deployment of multiple ATMs. Instead of individual placement agreements, a master agreement with a regional or national chain could provide a scalable growth avenue. These partnerships could also include co-branding opportunities or exclusive placement rights, enhancing visibility and transaction volume. Such collaborations would require demonstrating reliable service and competitive transaction fee structures to potential partners.
• Targeting Underserved Markets: Focus on areas with limited access to traditional banking services or where cash remains a predominant form of transaction. This includes rural communities, certain urban neighborhoods, or specific event venues. By strategically placing ATMs in these underserved locations, THC Farmaceuticals, Inc. can capture a market segment with consistent demand for cash. This approach requires careful market analysis to identify optimal locations and understand local cash usage patterns, ensuring high utilization rates for new deployments.

What Threats Does CBDG Face?

• Increasing adoption of digital payment methods reducing demand for cash.
• Intense competition from larger independent ATM operators and traditional banks.
• Regulatory changes impacting ATM operations or transaction fees.
• Operational risks associated with maintaining a small, geographically concentrated network.

What Are CBDG's Competitive Advantages?

• Established network of ATM placements in specific high-footfall areas (as of 2015).
• Operational experience in managing independent ATM services since 2008.
• Strategic relationships with third-party establishments for ATM placement.
• Focus on specific geographic regions, potentially creating local market familiarity.

What Does CBDG Do?

THC Farmaceuticals, Inc. is a company specializing in the ownership and operation of independent (non-bank) automated teller machines (ATMs). Founded in 2008, the company initially operated under the name City Media, Inc. before adopting its current name, THC Farmaceuticals, Inc., in February 2015. Headquartered in Scottsdale, Arizona, the company strategically places its cash-dispensing units within various third-party retail and commercial establishments. These locations are carefully selected for their high customer footfall, including venues such as hotels, stores, and bowling alleys, with the aim of serving both individual consumers and small to medium-sized enterprises (SMEs) that rely on cash transactions. As of June 30, 2015, THC Farmaceuticals, Inc. reported an operational network comprising eight public-access ATMs. This network was concentrated exclusively within Utah's Wasatch Front region, indicating a highly localized operational focus. The company's business model is centered on providing convenient access to cash in areas where traditional banking services might be less accessible or where establishments prefer cash-based transactions. THC Farmaceuticals, Inc. functions as a subsidiary of Weed Growth Fund, Inc., integrating its ATM operations within the broader portfolio of its parent company. Despite its sector classification as Healthcare and industry as Biotechnology, its core business remains the provision of ATM services.

What Products and Services Does CBDG Offer?

• Owns and operates independent Automated Teller Machines (ATMs).
• Places ATMs in third-party retail and commercial establishments.
• Targets high-footfall locations such as hotels, stores, and bowling alleys.
• Aims to serve small and medium-sized enterprises (SMEs) with cash access.
• Operated a network of eight public-access ATMs as of June 30, 2015.
• Primarily focused on Utah's Wasatch Front region.
• Functions as a subsidiary of Weed Growth Fund, Inc.

How Does CBDG Make Money?

• Generates revenue through transaction fees charged for ATM withdrawals and inquiries.
• Leverages strategic placement in third-party venues to maximize customer access and transaction volume.
• Maintains a network of independent ATMs, managing their operation and maintenance.
• Operates with a lean structure, indicated by its small employee count.

What Industry Does CBDG Operate In?

THC Farmaceuticals, Inc. operates within the independent ATM segment, which is part of the broader financial services infrastructure, despite its official classification under the Healthcare sector and Biotechnology industry. This segment caters to the persistent demand for physical cash, particularly in retail and commercial establishments that may not host traditional bank ATMs or prefer independent solutions. The market is influenced by the ongoing shift towards digital payments, which poses a long-term challenge, yet also by the continued need for cash among certain consumer demographics and small businesses. Competition arises from other independent ATM operators, traditional banks with their own ATM networks, and increasingly, digital payment solutions. With only eight ATMs reported in 2015 and a focus on Utah's Wasatch Front, THC Farmaceuticals, Inc. holds a very small, localized position within this competitive landscape, requiring strategic agility to navigate market trends.

Who Are CBDG's Key Customers?

• Individuals needing cash access in retail and commercial settings.
• Customers of hotels, stores, and bowling alleys where ATMs are located.
• Small and medium-sized enterprises (SMEs) whose customers rely on cash transactions.
• General public in Utah's Wasatch Front region requiring ATM services.

Company Profile

THC Farmaceuticals, Inc. operates in the Biotechnology industry within the Healthcare sector. It is headquartered in Scottsdale, US. The company is led by CEO Mark D. Grossman. CBDG has traded publicly since 2014.

THC Farmaceuticals, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.28 places it in the distress zone, a signal of elevated financial risk.

Return on equity for THC Farmaceuticals, Inc. stands at -0.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -0.4%, showing how much profit it generates from its asset base. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -5.2%, the inverse of the P/E and a quick read on earnings relative to price.

CBDG Valuation & Market Position

Relative to its peer group, CBDG's quantitative score of 42/100 is below the peer average of 76/100.

CBDG Financials

CBDG Latest News

No recent news available for CBDG.

CBDG Analyst Consensus

CBDG MoonshotScore

Common Questions About CBDG (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources